chrX-18650469-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP5BP4
This summary comes from the ClinGen Evidence Repository: RS1(NM_000330.4) and an alternative transcript of CDKL5 (NM_003159.2) are overlapping transcripts; however, these variants are in the noncoding 3' region of the main CDKL5 transcript (NM_001323289.2). The c.2857G>T (p.Ala953Ser) variant in CDKL5 transcript (NM_003159.2) (RS1 c.185-3137C>A) is present in 2 male individuals in gnomAD (0.002%) (not sufficient to meet BS1 criteria). The p.Ala953Ser variant is found in a patient with an alternate molecular basis of disease (internal database - Invitae) (BP5). Additionally, computational analysis prediction tools suggest that the p.Ala953Ser variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Ala953Ser variant in CDKL5 (NM_003159.2) is classified as likely benign based on the ACMG/AMP criteria (BP5, BP4). LINK:https://erepo.genome.network/evrepo/ui/classification/CA10360734/MONDO:0100039/034
Frequency
Consequence
ENST00000379989.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RS1 | NM_000330.4 | c.185-3137C>A | intron_variant | ENST00000379984.4 | NP_000321.1 | |||
CDKL5 | NM_001037343.2 | c.2857G>T | p.Ala953Ser | missense_variant | 21/22 | NP_001032420.1 | ||
CDKL5 | NM_003159.3 | c.2857G>T | p.Ala953Ser | missense_variant | 20/21 | NP_003150.1 | ||
RS1 | XM_047442337.1 | c.-86C>A | 5_prime_UTR_variant | 1/4 | XP_047298293.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RS1 | ENST00000379984.4 | c.185-3137C>A | intron_variant | 1 | NM_000330.4 | ENSP00000369320 | P1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183508Hom.: 0 AF XY: 0.0000294 AC XY: 2AN XY: 67938
GnomAD4 exome AF: 0.0000127 AC: 14AN: 1098130Hom.: 0 Cov.: 30 AF XY: 0.0000193 AC XY: 7AN XY: 363490
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 14, 2016 | - - |
CDKL5 disorder Benign:1
Likely benign, reviewed by expert panel | curation | ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel | Feb 20, 2023 | RS1(NM_000330.4) and an alternative transcript of CDKL5 (NM_003159.2) are overlapping transcripts; however, these variants are in the noncoding 3' region of the main CDKL5 transcript (NM_001323289.2). The c.2857G>T (p.Ala953Ser) variant in CDKL5 transcript (NM_003159.2) (RS1 c.185-3137C>A) is present in 2 male individuals in gnomAD (0.002%) (not sufficient to meet BS1 criteria). The p.Ala953Ser variant is found in a patient with an alternate molecular basis of disease (internal database - Invitae) (BP5). Additionally, computational analysis prediction tools suggest that the p.Ala953Ser variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Ala953Ser variant in CDKL5 (NM_003159.2) is classified as likely benign based on the ACMG/AMP criteria (BP5, BP4). - |
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 14, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at